The IJTLD
The IJTLD is the leading peer-reviewed journal dedicated to lung health worldwide.
We welcome submissions on basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
Public Health Action
Public Health Action aims to disseminate the latest operational research on health systems, public health and disease control.
We have recently expanded the scope of PHA to provide coverage of relevant areas of the UN's Sustainable Development Goals (SDGs).
IJTLD Open
IJTLD Open is The Union's Open Access journal for the latest research on infectious diseases, including TB and non-tuberculous mycobacterial (NTM), along with the role of risk factors and comorbidities.
We welcome submissions on the development of diagnostics and treatments for the prevention, management and control of respiratory diseases.
IJTLD CRD
Launching in 2026, IJTLD CRC is The Union's new Open Access journal for the latest research on chronic respiratory diseases.
We welcome submissions on the development of diagnostics and treatments for the care, management and rehabilitation of patients with respiratory disease.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
The impact of COVID-19 on TB: a review of the data
In this recently accepted Review for IJTLD, the authors summarise the evidence available at a country level, identifying broad mechanisms by which COVID-19 may modify TB burden and mitigation efforts.
Tackling TB and COVID-19: US leadership is needed on global health, now more than ever
In the lead up to World TB Day, an article in PHA calls for increased funding and renewed leadership to coordinate the global fight against TB. A relatively small investment in TB control has the potential to transform TB care, saving millions of lives and trillions of dollars in the global economy.
Impact of influenza A co-infection with COVID-19
This study reports on the rate of co-infection with influenza A in a cohort of COVID-19 patients and its impact on the clinical course and outcome.